Abstract
The study investigates the anti-diabetic properties of linsseed (Linum usitatissimum L.) sprout extracts in adult streptozotocin (STZ)-induced Long-Evan rats, addressing the limitations of existing treatment strategies in Bangladesh. The diabetic rats were administered orally with 400 mg/kg body weight of methanolic extracts of linseed sprout with a lab diet and glibenclamide as a positive control. Blood sugar levels were measured before, after, and after STZ injection in Long- Evan rats. The lipid profiles and liver function tests were performed. Administration of extracts of linseed sprouts and a standard anti-diabetic drug reduced the glucose level from 9.1 mmol/l to 6.0 mmol/l and 10.5 mmol/l to 6.6 mmol/l , respectively. The study also showed a healthy level of liver function tests and lipid profiles. The in vivo analysis of the potential antidiabetic activity of linseed sprouts in the STZ-induced diabetic mouse model might be used to treat and manage diabetes. Bangladesh J. Bot. 53(3): 503-510, 2024 (September)
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
